Your browser doesn't support javascript.
loading
The heavy chain of 4F2 antigen promote prostate cancer progression via SKP-2.
Maimaiti, Maihulan; Sakamoto, Shinichi; Sugiura, Masahiro; Kanesaka, Manato; Fujimoto, Ayumi; Matsusaka, Keisuke; Xu, Minhui; Ando, Keisuke; Saito, Shinpei; Wakai, Ken; Imamura, Yusuke; Nakayama, Keiichi; Kanai, Yoshikatsu; Kaneda, Atsushi; Ikehara, Yuzuru; Ikeda, Jun-Ichiro; Anzai, Naohiko; Ichikawa, Tomohiko.
Afiliação
  • Maimaiti M; Department of Urology, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba, 260-8670, Japan.
  • Sakamoto S; Department of Tumor Pathology, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Sugiura M; Department of Urology, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba, 260-8670, Japan. rbatbat1@gmail.com.
  • Kanesaka M; Department of Urology, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba, 260-8670, Japan.
  • Fujimoto A; Department of Molecular Oncology, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Matsusaka K; Department of Urology, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba, 260-8670, Japan.
  • Xu M; Department of Molecular Oncology, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Ando K; Department of Urology, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba, 260-8670, Japan.
  • Saito S; Department of Pathology, Chiba University Hospital, Chiba, Japan.
  • Wakai K; Bio-System Pharmacology, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Imamura Y; Department of Urology, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba, 260-8670, Japan.
  • Nakayama K; Department of Pharmacology, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Kanai Y; Department of Urology, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba, 260-8670, Japan.
  • Kaneda A; Department of Pharmacology, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Ikehara Y; Department of Urology, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba, 260-8670, Japan.
  • Ikeda JI; Department of Tumor Pathology, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Anzai N; Department of Urology, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba, 260-8670, Japan.
  • Ichikawa T; Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.
Sci Rep ; 11(1): 11478, 2021 06 01.
Article em En | MEDLINE | ID: mdl-34075107
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Fase de Repouso do Ciclo Celular / Fase G1 / Cadeia Pesada da Proteína-1 Reguladora de Fusão / Proteínas Quinases Associadas a Fase S / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Fase de Repouso do Ciclo Celular / Fase G1 / Cadeia Pesada da Proteína-1 Reguladora de Fusão / Proteínas Quinases Associadas a Fase S / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article